SYQUANT CAPITAL SAS

PARIS, I0 How do I update this listing?

Syquant Capital SAS is based out of Paris. Their last reported 13F filing for Q1 2019 included $258,440,000 in managed 13F securities and a top 10 holdings concentration of 93.24%. Syquant Capital SAS's largest holding is Spark Therapeutics Inc with shares held of 558,524. Whalewisdom has at least 2 13F filings

Download 13F Summary to Excel Create Email Alert

03/31/2019

13F Sector Allocation Over Time

03/31/2019

13F Activity

  • Market Value $258.44 Million
  • Prior Market Value $116.918 Million
  • New Purchases11 stocks
  • Additional Purchases2 stocks
  • Sold out of7 stocks
  • Reduced holdings in1 stock
  • Top 10 Holdings % 93.24 %
  • Turnover % [1]:120.00%
  • Turnover Alt % [2]: 75.29 %
  • Time Held Top20:0.27 quarters
  • Time Held Top10:0.40 quarters
  • Time Held All:0.27 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

Portfolio Performance

Top 20 equal-weighted holdings. Performance numbers calculated through 2019-02-14

Performance for Q4 2018: -2.52%
Performance Last 4 Quarters: 0.0%
Performance Metrics
Stats are not available for the latest quarter

Refresh Advanced Export Download CSV Download Excel (.xlsx) Download TSV
Filter by:

Security Types:

Refresh
*Shares are split adjusted
Click here to report any possible errors with this listing.
13F Filings Available:
  • 2019-03-31 - 13F-HR (Subscription required)
  • 2018-12-31 - 13F-HR (Subscription required)

Active Schedule 13D and 13G events

Sign in to see

Form 4 - Recent Insider Transactions

Loading...

Elevate your investments